International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-100
SponsorRadboud University Medical Center

About this trial

To prospectively assess the incidence of peritoneal carcinomatosis for women with isolated STIC (serous tubal intraepithelial carcinoma). Moreover, to identify histopathological characteristics of STIC which are reproducible and associated to the risk of peritoneal carcinomatosis and to report the findings of additional diagnostics.

Eligibility criteria

Qualifiers

Women

Bilateral salpingectomy (with or without oophorectomy)

A serous tubal intraepithelial carcinoma at histopathological review

Disqualifiers

Invasive cancer at initial surgery or pathological examination (either macroscopic and/or microscopic)

Trial design

Treatments tested in this trial

  • No intervention, only registration

Treatment groups

600 Participants
are divided into 2 treatment groups

Locations

This trial has no locations